Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 246 participants.

Also called NCT01097967

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 246 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01097967
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Italy, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01097967. Randomized; no masking; primary purpose prevention. Start 2010-07 (registry gives no type); primary completion 2016-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy
Acronym
SAS-CARE
Intervention (Other)
CPAP
Lead sponsor
Prof. Claudio Bassetti (class: other government)
Collaborator
Swiss National Science Foundation (class: other)
Collaborator
Schweizerische Herzstiftung (class: other)
Collaborator
ResMed (class: industry)
Collaborator
Philips Respironics (class: industry)

Record details

Record id
cardio:ct-nct01097967
Content hash
8a35b97e79ed6ab915e5ec55155bf04c5df36c37971c8178e468019b2bcc4f97